IDE and diabetes mellitus: Hepatic ablation of IDE in knock‐out mouse models produces HI and glucose intolerance [16, 17], whereas in obese humans, reduction of IDE activity aggravates the HI and facilitates the onset of type 2 diabetes mellitus [3, 6, 15].